The Fatal Overdose Reduction Act of 2025 establishes a Medicaid demonstration program to create "Health Engagement Hubs" that provide comprehensive, drop-in services for people with opioid use disorder and other substance use disorders. These hubs would offer harm reduction services, medication-assisted treatment, counseling, and social services like housing assistance and job training, with a focus on communities disproportionately impacted by overdose deaths. States would develop payment systems for these services, with up to 10 states selected to participate for 5 years, and would be required to report on outcomes like overdose rates and treatment access. The program would be funded through a $60 million planning grant and would require states to track demographic and health outcomes to assess effectiveness.
This bill reauthorizes a federal program supporting pregnant and postpartum women with substance use disorders. It increases annual funding from $29.9 million to $38.9 million for fiscal years 2025-2029, updates terminology to "health care services," and requires applicants to include outreach plans targeting women disproportionately impacted by maternal substance use disorder. The program directly affects eligible women seeking treatment during pregnancy and postpartum, ensuring continued access to care through expanded funding and targeted outreach. The changes apply to the existing Public Health Service Act program (Section 508) without altering its core purpose.
This bill requires the Veterans Health Administration to expand its existing informed consent directive (currently covering long-term opioid therapy) to include written consent for five additional medication categories: antipsychotics, stimulants, antidepressants, anxiolytics, and narcotics. It directly affects Veterans receiving VA care for these specific medications, mandating that providers obtain written informed consent before prescribing them. The key mechanism is updating VA Directive 1005 to explicitly apply to these new medication types, ensuring consistent consent processes across VA treatment. This change applies only to VA healthcare settings, not to civilian medical practices.
The BEACON Act of 2026 establishes two grant programs to improve treatment for veterans with chronic mild traumatic brain injury (mTBI). It authorizes $30 million over three years for grants to nonprofits, academic institutions, and health providers to develop and test non-drug neurorehabilitation approaches, focusing on mental health outcomes, suicide risk reduction, and long-term recovery. The bill requires grantees to prioritize patient-centered care, conduct clinical studies, and partner with VA facilities, with each grant capped at $5 million annually. A separate $10 million annual program funds independent research on TBI treatments, requiring third-party analysis and annual reports to Congress. The pilot programs expire after three years, with evaluations to determine future expansion.
S 1843, the Second Chance Reauthorization Act of 2025, extends funding for existing federal reentry programs through 2030 instead of 2023. It updates timeframes across multiple programs, including state reentry demonstration projects (adding substance use disorder treatment and housing services), family-based substance abuse grants, prison education evaluations, career training for incarcerated individuals, and community mentoring programs. These programs directly support people returning from incarceration by providing critical services like recovery support, job training, and transitional housing. The bill makes no new policy changes but continues current federal funding mechanisms for reentry assistance.
S 916 prohibits the detention of pregnant, lactating, or postpartum noncitizens in immigration custody, requiring their immediate release except in rare cases involving credible safety threats. It bans all physical restraints during pregnancy, labor, delivery, and postpartum recovery, with strict limits on exceptions. The bill mandates access to comprehensive reproductive healthcare, including prenatal care, labor services, and postpartum support, while requiring facilities to provide medical consent and maintain detailed reporting on detention practices. These provisions apply directly to noncitizens held by U.S. Immigration and Customs Enforcement (ICE) or U.S. Customs and Border Protection (CBP) facilities.
The Safe Response Act (S 2532) amends the Public Health Service Act to update first responder training requirements for overdose response. It broadens training to cover "opioid, heroin, and other drug" overdoses (replacing previous opioid-specific language) and updates product terminology to include "approved, cleared, or otherwise legally marketed" medical devices. The bill also adjusts funding, increasing annual support for the program from $36 million (2019-2023) to $57 million (2026-2030). These changes directly affect first responders and tribal programs receiving federal training funds, ensuring training aligns with current drug use patterns and medical product standards.
HR 4837, the Written Informed Consent Act, requires the Veterans Health Administration (VHA) to update its existing directive on informed consent to include additional medication classes. Specifically, it mandates that written informed consent must be obtained before prescribing antipsychotics, stimulants, antidepressants, anti-anxiety medications (anxiolytics), and narcotics (opioids) to veterans. This expansion directly affects veterans receiving these medications through the VA system, ensuring they are informed about specific treatment risks and alternatives. The key mechanism is amending VHA Directive 1005 to broaden its application beyond long-term opioid therapy to cover the newly listed medication types.
S 1878, the ATTAIN Mental Health Act, requires the U.S. Department of Health and Human Services to create a public online dashboard within two years of enactment. This dashboard will list all federal mental health and substance use disorder grant programs, including current application status (open/closed/awarded) and deadlines, and allow users to search by location or topic. It will integrate state-level grant information where available and link directly to application pages, making it easier for schools, clinics, tribal organizations, nonprofits, and other potential applicants to find funding opportunities. The dashboard must comply with accessibility standards and be updated continuously to reflect current grant opportunities.
This bill requires the Department of Defense's Transition Assistance Program (TAP) and the Department of Veterans Affairs' Solid Start Program to provide servicemembers and veterans with specific, standardized mental health information during their transition from military to civilian life. It mandates inclusion of details on suicide risk factors (like depression, homelessness, and relationship strain), PTSD treatment options, substance abuse resources, and the impact of losing military support networks. Both programs must cover these topics in their counseling materials, directly affecting active-duty service members separating from the military and newly enrolled veterans. The bill also requires the Defense and Veterans Affairs Secretaries to jointly report to Congress within one year on the implementation of these changes.
